Werfen's 60th Anniversary: A Celebration of Healthcare Professionals
Introduction
In November 2026, Werfen, a leader in In Vitro Diagnostics (IVD), marked its 60th anniversary with a heartfelt campaign aimed at recognizing the invaluable contributions of healthcare professionals and laboratory teams. This unique initiative, titled 'Thank You,' seeks to highlight the significance of IVD in enhancing patient care worldwide.
The Role of In Vitro Diagnostics
IVD is crucial in clinical decisions, affecting about 70% of medical choices globally. From determining kidney transplant compatibility to managing chronic illnesses during complex surgeries, the role of reliable diagnostic data cannot be overstated. Despite its importance, much of the work within laboratories occurs behind the scenes. The 'Thank You' campaign aims to bring this vital aspect into the spotlight through a powerful short film featuring real patients and their stories.
Impactful Storytelling
The campaign's short film showcases testimonials from real patients who have navigated challenging health conditions. Each story expresses gratitude towards healthcare teams for their expertise in interpreting test results, which guides effective treatment decisions. Collaboration with patient associations and non-profit organizations further emphasizes the significance of diagnostics across various medical conditions, including lupus, thalassemia, hemophilia, and complex surgeries.
Corporate Commitment
Alejandro Risso, CEO of Werfen, stated, "For 60 years, Werfen has been dedicated to supporting healthcare professionals during pivotal moments in their patients' lives. Our responsibility is to deliver the utmost analytical precision, allowing professionals to make confident decisions when they matter most." This commitment has propelled Werfen's growth as a multinational entity specializing in IVD, with a presence in over 30 countries.
Historical Journey
Founded in 1966 in Barcelona, Spain, Werfen has evolved significantly over the past six decades. The company has consistently focused on innovation, allocating significant resources towards research and development in the field of IVD. In 2025 alone, Werfen invested 190 million euros to advance diagnostic science, reinforcing its dedication to improving patient outcomes.
Innovation at the Core
Werfen's innovation encompasses various areas: Coagulation, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplantation. By merging scientific rigor, clinical relevance, and reliability, the company has ensured that laboratories, hospitals, and healthcare professionals have access to diagnostic tools that facilitate excellent patient care.
Conclusion
As Werfen commemorates its 60th anniversary, the 'Thank You' campaign not only acknowledges the hard work of healthcare professionals but also inspires a broader conversation about the importance of diagnostics in medical care. Through this initiative, Werfen reaffirms its commitment to empowering those who save and enhance lives every day. For more information, visit
werfen.com/thankyou.